COMP <GO>
DCTH vs SGHT // RSI-14 & 200D SMA MOMENTUM
Delcath Systems Inc. (NASDAQ) VS. Sight Sciences Inc. (NASDAQ) • 15-METRIC TALLY: DCTH 7
— SGHT 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SGHT
LAST: $14.64 (-1.48%) • MKT CAP: $508.0M
rsi-technicals
37.3
LAST: $9.57 (+3.57%) • MKT CAP: $527.2M
rsi-technicals
59.3
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. SGHT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCTH | SGHT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.20% | 86.20% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | -35.00% | +35.80 | DCTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.13% | -5.67% | +9.80 | DCTH | /fcf-yield <GO> |
| Operating Margin | 0.80% | -48.00% | +48.80 | DCTH | /operating-margins <GO> |
| Net Profit Margin | 3.20% | -49.70% | +52.90 | DCTH | /net-margins <GO> |
| Revenue Growth (YoY) | 129.10% | -3.10% | +132.20 | DCTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 20.33 | 2.16 | +18.17 | DCTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | DCTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 37.3 | 59.3 | -22.02 | SGHT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $508.0M | $527.2M | -$19.2M | SGHT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCTH REV | SGHT REV | DCTH GROSS % | SGHT GROSS % | DCTH FCF | SGHT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $85.2M | $77.4M | 86.2% | 86.2% | $21.0M | -$29.9M |
| FY 2024 | $37.2M | $79.9M | 83.4% | 85.5% | -$19.2M | -$22.7M |
| FY 2023 | $2.1M | $81.1M | — | — | -$31.3M | -$47.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
SGHT // BETA —